4.7 Article

Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer

Journal

Publisher

MDPI
DOI: 10.3390/ijms23084117

Keywords

photodynamic therapy; photosensitizer; protoporphyrin IX; heme metabolism; multidrug resistance; DNA repair; APE1; combined therapy; APE1 inhibitor

Funding

  1. National Science Centre, Poland [2014/15/B/NZ5/01444]
  2. Centre for Preclinical Research and Technology (CePT) - European Regional Development Fund
  3. National Cohesion Strategy of Poland

Ask authors/readers for more resources

Photodynamic therapy (PDT) is a valuable treatment method for vulvar intraepithelial neoplasia (VIN) as it allows for minimal tissue destruction and treatment of multifocal disease. However, resistance to PDT in vulvar cancer may be due to alterations in the heme synthesis pathway and increased activity of the DNA repair protein APE1. Inhibition of APE1 activity may enhance the efficacy of PDT.
Photodynamic therapy (PDT) is a valuable treatment method for vulvar intraepithelial neoplasia (VIN). It allows for the treatment of a multifocal disease with minimal tissue destruction. 5-Aminolevulinic acid (5-ALA) is the most commonly used prodrug, which is converted in the heme pathway to protoporphyrin IX (PpIX), an actual photosensitizer (PS). Unfortunately, not all patients treated with PDT undergo complete remission. The main cause of their failure is resistance to anticancer therapy. In many cancers, resistance to various anticancer treatments is correlated with increased activity of the DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1). Enhanced activity of drug pumps may also affect the effectiveness of therapy. To investigate whether multidrug resistance mechanisms underlie PDT resistance in VIN, porphyrins were isolated from sensitive and resistant vulvar cancer cells and their culture media. APE1 activity was measured, and survival assay after PDT combined with APE1 inhibitor was performed. Our results revealed that resistant cells accumulated and effluxed less porphyrins than sensitive cells, and in response to PDT, resistant cells increased APE1 activity. Moreover, PDT combined with inhibition of APE1 significantly decreased the survival of PDT-resistant cells. This means that resistance to PDT in vulvar cancer may be the result of alterations in the heme synthesis pathway. Moreover, increased APE1 activity may be essential for the repair of PDT-mediated DNA damage, and inhibition of APE1 activity may increase the efficacy of PDT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available